These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
6. Effect of KRAS Mutation on Long-Term Outcomes of Patients Undergoing Hepatic Resection for Colorectal Liver Metastases. Margonis GA; Spolverato G; Kim Y; Karagkounis G; Choti MA; Pawlik TM Ann Surg Oncol; 2015 Dec; 22(13):4158-65. PubMed ID: 26077912 [TBL] [Abstract][Full Text] [Related]
7. Clinical significance and prognostic relevance of KRAS, BRAF, PI3K and TP53 genetic mutation analysis for resectable and unresectable colorectal liver metastases: A systematic review of the current evidence. Tsilimigras DI; Ntanasis-Stathopoulos I; Bagante F; Moris D; Cloyd J; Spartalis E; Pawlik TM Surg Oncol; 2018 Jun; 27(2):280-288. PubMed ID: 29937183 [TBL] [Abstract][Full Text] [Related]
8. Association Between Specific Mutations in KRAS Codon 12 and Colorectal Liver Metastasis. Margonis GA; Kim Y; Spolverato G; Ejaz A; Gupta R; Cosgrove D; Anders R; Karagkounis G; Choti MA; Pawlik TM JAMA Surg; 2015 Aug; 150(8):722-9. PubMed ID: 26038887 [TBL] [Abstract][Full Text] [Related]
9. Differential effects of KRAS mutational status on long-term survival according to the timing of colorectal liver metastases. Sakai N; Furukawa K; Takayashiki T; Kuboki S; Takano S; Ohtsuka M BMC Cancer; 2021 Apr; 21(1):412. PubMed ID: 33858364 [TBL] [Abstract][Full Text] [Related]
10. Codon 13 KRAS mutation predicts patterns of recurrence in patients undergoing hepatectomy for colorectal liver metastases. Margonis GA; Kim Y; Sasaki K; Samaha M; Amini N; Pawlik TM Cancer; 2016 Sep; 122(17):2698-707. PubMed ID: 27244540 [TBL] [Abstract][Full Text] [Related]
11. Effect of KRAS and BRAF Mutations on Survival of Metastatic Colorectal Cancer After Liver Resection: A Systematic Review and Meta-Analysis. Tosi F; Magni E; Amatu A; Mauri G; Bencardino K; Truini M; Veronese S; De Carlis L; Ferrari G; Nichelatti M; Sartore-Bianchi A; Siena S Clin Colorectal Cancer; 2017 Sep; 16(3):e153-e163. PubMed ID: 28216246 [TBL] [Abstract][Full Text] [Related]
12. The ALPPS Approach for Colorectal Liver Metastases: Impact of KRAS Mutation Status in Survival. Serenari M; Alvarez FA; Ardiles V; de Santibañes M; Pekolj J; de Santibañes E Dig Surg; 2018; 35(4):303-310. PubMed ID: 29032374 [TBL] [Abstract][Full Text] [Related]
13. Anatomical resection improves relapse-free survival in colorectal liver metastases in patients with KRAS/NRAS/BRAF mutations or right-sided colon cancer: a retrospective cohort study. Chang W; Chen Y; Zhou S; Ren L; Xu Y; Zhu D; Tang W; Ye Q; Wang X; Fan J; Wei Y; Xu J Int J Surg; 2023 Oct; 109(10):3070-3077. PubMed ID: 37526097 [TBL] [Abstract][Full Text] [Related]
14. Prognostic Implication of KRAS Status after Hepatectomy for Colorectal Liver Metastases Varies According to Primary Colorectal Tumor Location. Sasaki K; Margonis GA; Wilson A; Kim Y; Buettner S; Andreatos N; Gani F; Amini N; Spolverato G; Pawlik TM Ann Surg Oncol; 2016 Oct; 23(11):3736-3743. PubMed ID: 27352204 [TBL] [Abstract][Full Text] [Related]
15. KRAS mutation influences recurrence patterns in patients undergoing hepatic resection of colorectal metastases. Kemeny NE; Chou JF; Capanu M; Gewirtz AN; Cercek A; Kingham TP; Jarnagin WR; Fong YC; DeMatteo RP; Allen PJ; Shia J; Ang C; Vakiani E; D'Angelica MI Cancer; 2014 Dec; 120(24):3965-71. PubMed ID: 25155157 [TBL] [Abstract][Full Text] [Related]